About the MC2 Center
The Multi-Consortia Coordinating (MC2) Center supports several NCI Division of Cancer Biology (DCB)-funded consortia programs, which are made up of interdisciplinary communities of scientists. These scientists are working to integrate approaches, data, and tools to address important questions in basic and translational cancer research. The overarching goals of the MC2 Center are to a) use evidence-based infrastructure to catalyze collaboration and support engagement across the research community; b) improve interoperability and usability of DCB program data and tools; and c) support the growth of a strong and stable cancer research community beyond these DCB programs.
Led by Sage Bionetworks, a non-profit organization based in Seattle, Washington, the MC2 Center is made up of three operational hubs: the Collaboration Hub, the Resource Coordination Hub, and the Outreach Hub. These hubs are managed by Scientific Community Managers, Project Managers, Scientists, Biomedical Data Managers, and Bioinformatics Engineers. Sage Bionetworks also works in partnership with collaborators at Harvard, Yale, and the University of Colorado Anschutz. Through these hubs, the MC2 Center supports engagement, collaboration, and training across the investigators, early career researchers, patient advocates, and program directors that make up the MC2 Center Community. The MC2 Center also supports the dissemination and discovery of cancer research resources emerging from the MC2 Center Community (e.g. publications, computational tools, and datasets) through the maintenance of the Cancer Complexity Knowledge Portal.
With the MC2 Center Community spread out across the United States, most collaborative work takes place virtually. The community participates through online steering committees, working groups, special interest groups and in conversation through Slack workspaces. The MC2 Center also holds in-person Annual Investigator meetings, trainings, workshops, seminar series, and more.
The MC2 Center is funded by the NIH/NCI Division of Cancer Biology (U24 CA274494).